Drug Trial Radar · NCT04667078
REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts
Last checked: Nov 20, 2026Latest source record: Sep 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Suspended
Enrollment
368
Planned (sponsor's estimate)
Start
Mar 2, 2022
Primary completion
Dec 21, 2026
Study completion Dec 21, 2027
Sponsor
- Lead sponsor
- Fondation Ophtalmologique Adolphe de RothschildResearch network
- Sponsor type
- Research network
- Collaborators
- Ministry of Health, France
- First posted
- Dec 14, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective is to evaluate the efficacy of IV administration of the P2Y12 inhibitor (cangrelor) in addition to mecanich thrombectomy and WMD versus mecanich thrombectomy and WMD alone on the functional prognosis at 3 months, in patients with acute ischemic stroke eligible for mecanich thrombectomy on the basis of infusion imaging between 0 and 24 hours after the onset of symptoms.
Conditions
- Acute Ischemia
Interventions
CangrelorDrug
administration of cangrolor by iv befor thrombectomy
best medical managementOther
used yhe best medical management
Primary outcomes
What the sponsor says the trial is designed to measure.
- Favorable functional evaluation at 3 month for patients with acute ischemic strocke treated by cangrelor.Time frame: 3 months
Locations
13 sites in 1 country. Site status is shown where the registry gives one.
CHU de Besançon
Besançon, France
Hôpital Pellegrin (CHU de Bordeaux)
Bordeaux, France
Hospices civils de Lyon, Hôpital Pierre Wertheimer
Bron, France
Hôpital Salengro (CHU Lille)
Lille, France
Hôpital Dupuytren (CHU Limoges)
Limoges, France
CHU La Timone
Marseille, France
Hôpital Central (CHU de Nancy)
Nancy, France
Hôpital Lariboisière AP-HP
Paris, France
Hôpital Pitié-Salpêtrière AP-HP
Paris, France
Hôpital Fondation A de Rothschild
Paris, France
CHU de Strasbourg
Strasbourg, France
Hôpital Foch
Suresnes, France
Hôpital Purpan (CHU de Toulouse)
Toulouse, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.